 CAMBRIDGE, Mass., July 28, 2021 GLOBE NEWSWIRE -- Sarepta Therapeutics, Inc. NASDAQ:SRPT, the leader in precision genetic medicine for rare diseases, will report second quarter 2021 financial results after the Nasdaq Global Market closes on Wednesday, August 4, 2021. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its second quarter 2021 financial results and to provide a corporate update. 